| Type | Bioactive Small Molecules | Chelating Agents & Ligands | Dyes, Stains, & Indicators | Chelating Agents & Ligands | Proteins |
| Description | GRAMD1C Human Pre-designed siRNA Set A contains three designed siRNAs for GRAMD1C gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components GRAMD1C siRNA-1: 5 nmol (HPLC) GRAMD1C siRNA-2: 5 nmol (HPLC) GRAMD1C siRNA-3: 5 nmol (HPLC) siRNA GRAMD1C Human Pre-designed siRNA Set A contains three designed siRNAs for GRAMD1C gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components GRAMD1C siRNA-1: 5 nmol (HPLC) GRAMD1C siRNA-2: 5 nmol (HPLC) GRAMD1C siRNA-3: 5 nmol (HPLC) siRNA Negative Control: 5 nmol (HPLC) FAM-labeled siRNA Negative Control: 5 nmol (HPLC) GAPDH siRNA Positive Control:5 nmol (HPLC)... Read More | Inquire | Amine-Reactive probe which passively diffuse into cells and it is nonfluorescent until the acetate groups are cleaved by intracellular esterases to yield the highly fluorescent, amine-reactive fluorophore. Upon reaction with amine-containing residues of intracellular proteins, these probes form dye Amine-Reactive probe which passively diffuse into cells and it is nonfluorescent until the acetate groups are cleaved by intracellular esterases to yield the highly fluorescent, amine-reactive fluorophore. Upon reaction with amine-containing residues of intracellular proteins, these probes form dye protein adducts that are well retained in cells as they move and divide during embryonic development.A Non-fluorescent cell permeant amine-reactive probe for long term tracing of cell... Read More | Amyloid β-Protein Fragment 25-35 (Aβ25-35) is derived from the amyloid-β protein.amyloid-β protein, which is mapped to human chromosome 21q21.Aβ25-35 lacks the N-terminal domain and the metal binding site and is majorly generated by proteolytic cleavage of Aβ(1−40Amyloid β-Protein Fragment 25-35 (Aβ25-35) is derived from the amyloid-β protein.amyloid-β protein, which is mapped to human chromosome 21q21.Aβ25-35 lacks the N-terminal domain and the metal binding site and is majorly generated by proteolytic cleavage of Aβ(1−40) peptides. It has a β-sheet and β-turn structure. Amino Acid Sequence Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-MetFunctional domain of Aβ required for both neurotrophic and neurotoxic effects... Read More | The Leuconostoc GPDH exhibits dual coenzyme specificity, namely NAD and NADP (Olive and Levy, Biochem., 6, 730 730, 1967). When assayed under conditions that are optimal for the particular coenzyme, the ratio of observed catalytic activity is NAD/NADP = 1.8 |